Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of 129.74 billion. The enterprise value is 141.91 billion.
Market Cap | 129.74B |
Enterprise Value | 141.91B |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
Earnings Date | Apr 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.02% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 19.06.
PE Ratio | 19.06 |
Forward PE | n/a |
PS Ratio | 2.66 |
PB Ratio | 1.54 |
P/TBV Ratio | 6.04 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 20.84 |
EV / Sales | 2.76 |
EV / EBITDA | 10.08 |
EV / EBIT | 12.97 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.46 |
Debt / FCF | n/a |
Interest Coverage | 15.62 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 6.28% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 589,029 |
Profits Per Employee | 82,148 |
Employee Count | 82,878 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.48% in the last 52 weeks. The beta is 0.48, so Sanofi's price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | +13.48% |
50-Day Moving Average | 109.89 |
200-Day Moving Average | 105.40 |
Relative Strength Index (RSI) | 50.48 |
Average Volume (20 Days) | 12,808 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of 48.82 billion and earned 6.81 billion in profits. Earnings per share was 5.45.
Revenue | 48.82B |
Gross Profit | 34.64B |
Operating Income | 10.25B |
Pretax Income | 8.50B |
Net Income | 6.81B |
EBITDA | 13.22B |
EBIT | 10.25B |
Earnings Per Share (EPS) | 5.45 |
Balance Sheet
The company has 8.17 billion in cash and 19.36 billion in debt, giving a net cash position of -11.19 billion.
Cash & Cash Equivalents | 8.17B |
Total Debt | 19.36B |
Net Cash | -11.19B |
Net Cash Per Share | n/a |
Equity (Book Value) | 84.15B |
Book Value Per Share | 66.83 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 70.96%, with operating and profit margins of 20.99% and 13.95%.
Gross Margin | 70.96% |
Operating Margin | 20.99% |
Pretax Margin | 17.41% |
Profit Margin | 13.95% |
EBITDA Margin | 27.09% |
EBIT Margin | 20.99% |
FCF Margin | n/a |
Dividends & Yields
Sanofi does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.02% |
Shareholder Yield | 0.02% |
Earnings Yield | 5.25% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |